Estimation and Comparison of Salivary Secretory Leukocyte Protease Inhibitor in Human Immunodeficiency Virus Patients and Healthy Individuals

AIM: Transmission of human immunodeficiency virus (HIV) in the oral cavity is a rare event, despite detectable virus in saliva and oropharyngeal tissues of infected persons, unlike other mucosal sites. Secretory leukocyte protease inhibitor (SLPI) has been suggested as the main soluble factor respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Pushpanshu, Kumar, Sathawane, Ramhari S, Kaushik, Rachna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931238/
https://www.ncbi.nlm.nih.gov/pubmed/24600179
http://dx.doi.org/10.4103/0973-1075.125551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931238/
https://www.ncbi.nlm.nih.gov/pubmed/24600179
http://dx.doi.org/10.4103/0973-1075.125551

Ejemplares similares